Search hospitals > Wisconsin > Rice Lake
Marshfield Medical Center-Rice Lake
Claim this profileRice Lake, Wisconsin 54868
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
293 reported clinical trials
23 medical researchers
Summary
Marshfield Medical Center-Rice Lake is a medical facility located in Rice Lake, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Marshfield Medical Center-Rice Lake is involved with conducting 293 clinical trials across 447 conditions. There are 23 research doctors associated with this hospital, such as Seth O. Fagbemi, Adedayo A. Onitilo, Chady A. Leon, MD, and Demet Gokalp Yasar.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
Top PIs
Seth O. FagbemiMarshfield Medical Center-EC Cancer Center4 years of reported clinical research
Studies Cancer
Studies Prostate Cancer
35 reported clinical trials
81 drugs studied
Adedayo A. OnitiloMarshfield Medical Center-Marshfield1 year of reported clinical research
Expert in Cancer
Studies Lung Cancer
24 reported clinical trials
89 drugs studied
Chady A. Leon, MDMarshfield Medical Center-Marshfield5 years of reported clinical research
Studies Leukemia
Studies Lymphoma
19 reported clinical trials
57 drugs studied
Demet Gokalp YasarMarshfield Medical Center-EC Cancer Center4 years of reported clinical research
Studies Cancer
Studies Breast Cancer
13 reported clinical trials
31 drugs studied
Clinical Trials running at Marshfield Medical Center-Rice Lake
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Renal Cell Carcinoma
Bladder Cancer
Squamous Cell Carcinoma
Bladder Carcinoma
Multiple Myeloma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Marshfield Medical Center-Rice Lake?
Marshfield Medical Center-Rice Lake is a medical facility located in Rice Lake, Wisconsin. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. Marshfield Medical Center-Rice Lake is involved with conducting 293 clinical trials across 447 conditions. There are 23 research doctors associated with this hospital, such as Seth O. Fagbemi, Adedayo A. Onitilo, Chady A. Leon, MD, and Demet Gokalp Yasar.